NCT01360229

Brief Summary

This is a single-center, double-blind, placebo-controlled trial to see if acupuncture can safety and effectively treat fatigue in Parkinson's Disease (PD). Eligible subjects will receive either real or sham acupuncture twice weekly for six weeks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
94

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2010

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

May 23, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 25, 2011

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2015

Completed
4.3 years until next milestone

Results Posted

Study results publicly available

August 12, 2019

Completed
Last Updated

August 12, 2019

Status Verified

July 1, 2019

Enrollment Period

4.3 years

First QC Date

May 23, 2011

Results QC Date

May 4, 2017

Last Update Submit

July 3, 2019

Conditions

Keywords

Parkinsons DiseaseFatigue

Outcome Measures

Primary Outcomes (1)

  • Change in the Modified Fatigue Impact Scale Total (MFIS) Between Treatment Groups

    The primary outcome measure will be the change between the baseline visit and 6-week time point in the Modified Fatigue Impact Scale Total (MFIS) between treatment groups. The range of the score is 0-84 with higher scores reflecting more severe fatigue.

    6 weeks

Study Arms (2)

Randomized Subjects receive a sham acupuncture.

SHAM COMPARATOR

Subjects will be randomized in a 1:1 ratio to receive either real or sham acupuncture.

Other: Acupuncture to treat fatigue in Parkinson disease

Randomized Subjects receive real acupuncture.

ACTIVE COMPARATOR

Subjects will be randomized in a 1:1 ratio to receive either real or sham acupuncture.

Procedure: Acupuncture

Interventions

AcupuncturePROCEDURE

Subjects will be randomized in a 1:1 ratio to receive real acupuncture. Acupuncture is a procedure in which specific body areas are pierced with fine needles for therapeutic purposes

Randomized Subjects receive real acupuncture.

Subjects will be randomized in a 1:1 ratio to receive sham acupuncture.

Randomized Subjects receive a sham acupuncture.

Eligibility Criteria

Age40 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with PD
  • Patients 40-99 years of age
  • Patients who have significant fatigue
  • Patients must be on a stable medication regimen for the treatment of PD

You may not qualify if:

  • Patients who have had previous acupuncture within the past six months
  • Patients who have had deep brain stimulation (DBS)
  • Patients with dementia, depression, or sleep disorder
  • Patients who are currently taking medications known to affect fatigue, such as stimulants

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Colorado Denver

Aurora, Colorado, 80045, United States

Location

Related Links

MeSH Terms

Conditions

Parkinson DiseaseFatigue

Interventions

Acupuncture Therapy

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Results Point of Contact

Title
Dr. Benzi Kluger
Organization
University of Colorado School of Medicine

Study Officials

  • Benzi Kluger, MD

    University of Colorado, Denver

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 23, 2011

First Posted

May 25, 2011

Study Start

August 1, 2010

Primary Completion

December 1, 2014

Study Completion

May 1, 2015

Last Updated

August 12, 2019

Results First Posted

August 12, 2019

Record last verified: 2019-07

Locations